TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2022

Phase II Study of Enzalutamide for Patients With Androgen Receptor-Positive Salivary Gland Cancers (Alliance A091404).

Alan L Ho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.